Tao Xu
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 12
- Hepatology top 5%
- Liver physiology and pathology 12
- Molecular Biology top 5%
- CRISPR and Genetic Engineering 11
- Circular RNAs in diseases 8
- RNA modifications and cancer 6
- Nephrology top 5%
- Immunology top 10%
-
- Liver Disease Diagnosis and Treatment 22
-
- Alcohol Consumption and Health Effects 12
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Tao Xu
116 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 723
- Hepatology 238
- Molecular Biology 1.6k
- Nephrology 134
- Immunology 303
Countries citing papers authored by Tao Xu
This map shows the geographic impact of Tao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Xu more than expected).
Fields of papers citing papers by Tao Xu
This network shows the impact of papers produced by Tao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Xu. The network helps show where Tao Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 16 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 15 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 10 | |
| 15 | 2021 | 85 | |
| 16 | 2021 | 8 | |
| 17 | 2020 | 16 | |
| 18 | 2020 | 63 | |
| 19 | 2014 | 21 | |
| 20 | 2013 | 6 |
About Tao Xu
Tao Xu is a scholar working on Hepatology, Cancer Research and Molecular Biology, having authored 127 papers that have together received 2.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Cancer-related molecular mechanisms research (14 papers), Liver physiology and pathology (12 papers), MicroRNA in disease regulation (12 papers), Alcohol Consumption and Health Effects (12 papers), CRISPR and Genetic Engineering (11 papers), Circular RNAs in diseases (8 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (723 citations), Hepatology (238 citations) and Molecular Biology (1.6k citations). Tao Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiao‐Ming Meng, Cheng Huang, Jun Li, Jizhong Zhou, Zhili He, Xiongwen Lv, Xiaohong Zhang, Xianxiang Xu, Xiang Meng and Cheng Zhi Huang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.